Notifications
Back
GLOBAL BIOBUSINESS FRONTIER
GLOBAL BIOBUSINESS FRONTIER


Becoming a global biopharmaceutical company via entering Songdo IFEZ



  • Strategic investor relations(promote investment from domestic & international investors)
  • Strategic investor supported by financial investors
  • Promotion of distributorship with strategic partner, by product & region
  • Promotion of individual contracts with local pharmaceutical distributors by country


글로벌 Standard cGMP 생산 공장 구축



  • 대지 면적 : 79,200 ㎡ (24,000 평)
  • 건평 : 158,400 ㎡ (48,000평)
  • 주요 시설 : 보툴리눔 cGMP, HA 원료 생산 공장, 의료기기 cGMP, 전시관 등  
  • 주력 생산품 : 보툴리눔 톡신, 히알루론산 원료 및 필러, 진단의료기기, 기능성 화장품 등